NEI Research News

The National Eye Institute (NEI), part of the National Institutes of Health, has awarded grants to five multi-disciplinary teams to develop new disease models for a range of eye conditions.

Researchers at the University of North Texas Health Science Center have shown that the MDM2 inhibitor class of drugs can treat uveitis in mice.

Delivery of corticosteroids directly into the eye is more effective than injections adjacent to the eye, according to results from a comparative clinical trial of macular edema in patients with noninfectious uveitis.

During aging, loss of vision and cognition often coincide. In a new study, researchers funded by the National Eye Institute (NEI) and the National Institute on Aging (NIA) have found that vision loss precedes loss of mental capacity.

Vision researcher, T. Michael Redmond, Ph.D., chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, is a recipient of the 2018 António Champalimaud Vision Award for foundational science discoveries about the molecular

Portable probe developed by Duke biomedical engineers makes it possible to capture images of photoreceptors in the eyes of young children.

Scientists funded by the National Eye Institute (NEI) report a novel gene therapy that halts vision loss in a canine model of a blinding condition called autosomal dominant retinitis pigmentosa (adRP).

Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors.

Research from MIT and Massachusetts Eye and Ear points to an autoimmune response as the driver of optic nerve damage in a mouse model of glaucoma.

Researchers from the University of Washington find link between certain eye conditions and the risk for Alzheimer's disease.